Structural basis for substrate specificity of Escherichia coli purine nucleoside phosphorylase

被引:87
作者
Bennett, EM
Li, CL
Allan, PW
Parker, WB
Ealick, SE [1 ]
机构
[1] Cornell Univ, Baker Lab, Dept Chem & Biol Chem, Ithaca, NY 14853 USA
[2] So Res Inst, Birmingham, AL 35205 USA
关键词
D O I
10.1074/jbc.M304622200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purine nucleoside phosphorylase catalyzes reversible phosphorolysis of purine nucleosides and 2'- deoxypurine nucleosides to the free base and ribose ( or 2'- deoxyribose) 1- phosphate. Whereas the human enzyme is specific for 6- oxopurine ribonucleosides, the Escherichia coli enzyme accepts additional substrates including 6- oxopurine ribonucleosides, 6- aminopurine ribonucleosides, and to a lesser extent purine arabinosides. These differences have been exploited in a potential suicide gene therapy treatment for solid tumors. In an effort to optimize this suicide gene therapy approach, we have determined the three- dimensional structure of the E. coli enzyme in complex with 10 nucleoside analogs and correlated the structures with kinetic measurements and computer modeling. These studies explain the preference of the enzyme for ribose sugars, show increased flexibility for active site residues Asp(204) and Arg(24), and suggest that interactions involving the 1- and 6- positions of the purine and the 4 '- and 5 '- positions of the ribose provide the best opportunities to increase prodrug specificity and enzyme efficiency.
引用
收藏
页码:47110 / 47118
页数:9
相关论文
共 61 条
[41]  
MESNIL M, 1997, KEYSTONE S, P67
[42]   MACROMODEL - AN INTEGRATED SOFTWARE SYSTEM FOR MODELING ORGANIC AND BIOORGANIC MOLECULES USING MOLECULAR MECHANICS [J].
MOHAMADI, F ;
RICHARDS, NGJ ;
GUIDA, WC ;
LISKAMP, R ;
LIPTON, M ;
CAUFIELD, C ;
CHANG, G ;
HENDRICKSON, T ;
STILL, WC .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 1990, 11 (04) :440-467
[43]   Processing of X-ray diffraction data collected in oscillation mode [J].
Otwinowski, Z ;
Minor, W .
MACROMOLECULAR CRYSTALLOGRAPHY, PT A, 1997, 276 :307-326
[44]  
OTWINOWSKI Z, 1993, P CCP4 STUD WEEK DAT, P56
[45]   Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells [J].
Parker, WB ;
Allan, PW ;
Shaddix, SC ;
Rose, LM ;
Speegle, HF ;
Gillespie, GY ;
Bennett, LL .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) :1673-1681
[46]   In vivo gene therapy of cancer with E-coli purine nucleoside phosphorylase [J].
Parker, WB ;
King, SA ;
Allan, PW ;
Bennett, LL ;
Secrist, JA ;
Montgomery, JA ;
Gilberg, KS ;
Waud, WR ;
Wells, AH ;
Gillespie, GY ;
Sorscher, EJ .
HUMAN GENE THERAPY, 1997, 8 (14) :1637-1644
[47]  
PARKS RE, 1972, ENZYMES, V7, P483
[48]   Thymidine kinase-deleted vaccinia virus expressing purine nucleoside phosphorylase as a vector for tumor-directed gene therapy [J].
Puhlmann, M ;
Gnant, M ;
Brown, CK ;
Alexander, HR ;
Bartlett, DL .
HUMAN GENE THERAPY, 1999, 10 (04) :649-657
[49]   The GB/SA continuum model for solvation. A fast analytical method for the calculation of approximate Born radii [J].
Qiu, D ;
Shenkin, PS ;
Hollinger, FP ;
Still, WC .
JOURNAL OF PHYSICAL CHEMISTRY A, 1997, 101 (16) :3005-3014
[50]   IMPROVED FOURIER COEFFICIENTS FOR MAPS USING PHASES FROM PARTIAL STRUCTURES WITH ERRORS [J].
READ, RJ .
ACTA CRYSTALLOGRAPHICA SECTION A, 1986, 42 :140-149